LifePoint Health (LPNT) Expected to Announce Quarterly Sales of $1.61 Billion

Equities analysts expect LifePoint Health (NASDAQ:LPNT) to announce sales of $1.61 billion for the current fiscal quarter, Zacks reports. Nine analysts have provided estimates for LifePoint Health’s earnings. The highest sales estimate is $1.64 billion and the lowest is $1.60 billion. LifePoint Health reported sales of $1.63 billion during the same quarter last year, which indicates a negative year over year growth rate of 1.2%. The company is scheduled to announce its next quarterly earnings results on Friday, April 27th.

According to Zacks, analysts expect that LifePoint Health will report full year sales of $1.61 billion for the current fiscal year, with estimates ranging from $6.24 billion to $6.41 billion. For the next financial year, analysts forecast that the business will post sales of $6.50 billion per share, with estimates ranging from $6.36 billion to $6.59 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow LifePoint Health.

How to Become a New Pot Stock Millionaire

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.04). LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the prior year, the business earned $1.07 EPS. The business’s revenue for the quarter was down 7.2% compared to the same quarter last year.



Several research firms have issued reports on LPNT. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Thursday, January 11th. Mizuho reissued a “hold” rating and issued a $51.00 price target on shares of LifePoint Health in a research note on Thursday, March 22nd. Robert W. Baird reissued a “buy” rating and issued a $54.00 price target on shares of LifePoint Health in a research note on Tuesday, March 27th. Royal Bank of Canada dropped their price target on LifePoint Health to $58.00 and set an “outperform” rating on the stock in a research note on Monday, February 26th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $46.00 price target (down previously from $50.00) on shares of LifePoint Health in a research note on Monday, February 26th. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $54.31.

In other LifePoint Health news, Chairman William F. Carpenter III purchased 21,368 shares of LifePoint Health stock in a transaction that occurred on Wednesday, February 28th. The stock was acquired at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the completion of the acquisition, the chairman now owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total value of $2,183,400.00. Following the transaction, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. Company insiders own 8.76% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the stock. US Bancorp DE grew its holdings in LifePoint Health by 62.4% during the fourth quarter. US Bancorp DE now owns 3,095 shares of the company’s stock worth $155,000 after purchasing an additional 1,189 shares during the period. Cerebellum GP LLC bought a new position in LifePoint Health during the fourth quarter worth about $126,000. Public Employees Retirement System of Ohio grew its holdings in LifePoint Health by 20.8% during the third quarter. Public Employees Retirement System of Ohio now owns 15,429 shares of the company’s stock worth $893,000 after purchasing an additional 2,660 shares during the period. Legal & General Group Plc grew its holdings in LifePoint Health by 4.4% during the third quarter. Legal & General Group Plc now owns 63,590 shares of the company’s stock worth $3,684,000 after purchasing an additional 2,664 shares during the period. Finally, New York State Common Retirement Fund grew its holdings in LifePoint Health by 3.2% during the third quarter. New York State Common Retirement Fund now owns 84,969 shares of the company’s stock worth $4,920,000 after purchasing an additional 2,669 shares during the period.

Shares of LPNT traded down $1.25 during midday trading on Friday, hitting $47.35. The stock had a trading volume of 253,252 shares, compared to its average volume of 576,530. LifePoint Health has a twelve month low of $41.45 and a twelve month high of $67.95. The company has a market capitalization of $1,847.54, a price-to-earnings ratio of 13.17, a P/E/G ratio of 1.44 and a beta of 0.50. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.70 and a quick ratio of 1.49.

ILLEGAL ACTIVITY WARNING: This news story was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://stocknewstimes.com/2018/04/21/lifepoint-health-lpnt-expected-to-announce-quarterly-sales-of-1-61-billion.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply